Jutras-Aswad, Didier

$4,986,431.00 CAD

≈ 64 Canadians' average pay for a year
Department
Canadian Institutes of Health Research
Program
Research in Priority Areas
Recipient country
Canada
Fiscal year
2022-2023
Agreement period
April 1, 2022 – March 31, 2026
Reference
cihr-irsc:236-2022-2023-Q1-00917

Published purpose

The specific objective of this funding opportunity are to: - provide the base/infrastructure funding to the CRISM Phase II Regional Nodes that will allow research teams to organize and collaborate to address critical research in the area of substance use, and to allow them to: o identify and develop clinical and community-based prevention or treatment interventions and guidelines, including harm reduction, for substance use o provide evidence to decision makers, providers and stakeholders, to support the enhancement of prevention or treatment services, as well as policy development, regarding substance use o engage Indigenous Peoples in Canada in research and KT efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance, such as following the First Nations Principles of OCAP® (i.e., Ownership, Control, Access and Possession), or employing a distinctions-based approach o support the improvement in the quality of care and quality of life for Canadians with substance use disorder o involve individuals with lived and living experience throughout the research process - conduct a Controlled Trial for management of methamphetamine use disorder aligned with the NIDA CTN

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions